Differential expression of human leukocyte antigen I between patients of Uighur and Han ethnic groups with cervical diseases

Tumor

Volumn 31, Issue 5, 2011, Pages 432-435

  Hasimu, Axiangu ^a   Sheng, Lei ^a   Ma, Qi ^a   Ma, Jun Qi ^a   Abudula, Abulizi ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Gene expression; Han ethnic group; Human leukocyte antigen I; Uighur ethnic group; Uterine cervical neoplasms

Indexed keywords

HLA ANTIGEN CLASS 1;

ANTIGEN EXPRESSION; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; ETHNIC GROUP; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; UTERINE CERVICITIS; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DISEASE;

EID: 79957471433     PISSN: 10007431     EISSN: None     Source Type: Journal    
DOI: 10.3781/j.issn.1000-7431.2011.05.010     Document Type: Article

References (14)

1. YANG B H, BRAY F I, PARKIN D M, et al. Cervical cancer as a priority for prevention in different world regions: an evaluation using years of life lost[J]. Int J Cancer, 2004,109(3):418-424.
2. MONSONEGO J. HPV infections and cervical cancer prevention. Priorities and new directions. Highlights of EUROGIN 2004 International Expert Meeting, Nice, France, October 21-23, 2004 [J]. Gynecol Oncol, 2005. 96(3):830-839.
3. KOOPMAN L A, CORVER W E, VAN DER SLIK A R, et al. Multiple genetical alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class¢ñ loss in cervical cancer [J]. J Exp Med, 2000, 191(6):961-976.
4. CHIL A, SIKORSKI M, BOBEK M, et al. Alterations in the expression of selected MHC antigens in premalignant lesions and squamous carcinomas of the uterine cervix[J]. Acta Obstet Gynecol Scand, 2003, 82(12):1146-1152.
5. PAULSSON K M. Evolutionary and functional perspectives of the major histocompatibility complex class I antigen-processing machinery[J]. Cell Mol Life Sci, 2004, 61(19-20):2446-2460.
6. AHANG Y, WILLIAMS D B. Assembly of MHC class I molecules within the endoplasmic reticulum [J]. Immunol Res, 2006, 35(1-2):151-162.
7. SELIGER B, RITZ U, FERRONE S. Molecular mechanisms of HLA class I antigen abnormalities following viral infection and transformation[J]. Int J Cancer, 2006, 118(1):129-138.
8. MACIAG P C, SCHLCHT N F, SOUZA P S, et al. Major histocompatibility complex and human papillomavirus infection in Brazilian women[J]. Cancer Epidemiol Biomakers Prev, 2000, 9(11):1183-1191.
9. CROMME F V, AIREY J, HEEMELS M T, et al. Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas[J]. J Exp Med, 1994, 179(1):335-340.
10. CROMME F V, VAN BOMMEL P F, WALBOOMERS J M, et al. Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumors[J]. Br J Cancer, 1994, 69(6):1176-1181.